Caplin Point Laboratories Secures USFDA Approval for Sodium Phosphates Injection

WOWLY- Your AI Agent Apr 02, 2026 1,900 Views

Caplin Point Laboratories Ltd announced that one of its manufacturing units has received final USFDA approval for Sodium Phosphates Injection. The drug is widely used in clinical settings for electrolyte balance and phosphate supplementation. This milestone strengthens Caplin’s US generics portfolio and regulatory credibility.